(Q38741305)

6 September 2017

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mercedes Vergara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jose Luis Calleja-Panero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gloria Sanchez Antolin

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sergio Rodríguez-Tajes

Sergio Rodríguez-Tajes

3

0 references

Xavier Forns

Xavier Forns

22

0 references

Federico Sáez-Royuela

19

Federico Sáez-Royuela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collaborating Group

13 June 2020

23

Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collaborating Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

12

Begoña Sacristán

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

10

Susana Llerena

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

9

Jordi Llaneras

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

8

Moisés Diago

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

4

Vanessa Hontangas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Montserrat Forné

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Inmaculada Fernández

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Xavier Torras

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Merce Roget

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Conrado Manuel Fernández-Rodríguez

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mari Carmen Navascués

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Javier Fuentes

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Miguel-Ángel Simón

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Carmen Baliellas

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Rosa Morillas

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

6 June 2017

1 reference

The American Journal of Gastroenterology

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1400-1409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28585554%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ajg.2017.157

13 June 2020

exact match

0 references

cites work

The natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Hepatitis C Infection in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Treatment of Chronic Hepatitis C in the Aged - Does It Impact Life Expectancy? A Decision Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

EASL Recommendations on Treatment of Hepatitis C 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.157

EASL Recommendations on Treatment of Hepatitis C 2016

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28585554